Tests like electrocardiograms or a blood test for cholesterol offer good measures of heart health. But the American College ...

The use of point-of-care testing for C-reactive protein to guide treatment lessened the use of antibiotics for COPD exacerbations without worsening clinical outcomes, according to a study published in ...

Please provide your email address to receive an email when new articles are posted on . Antibiotic prescribing in primary care practice for patients with COPD exacerbations is generally based on ...

Patients with COPD exacerbations are often treated with antibiotics. There are no clear biomarkers to determine which patients will benefit from these therapies, though. A management strategy using ...

Butler C, Gillespie D, White P, et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations [published online July 11, 2019]. N Engl J Med. doi: 10.1056/NEJMoa1803185.

Background: Point of care testing for C-reactive protein (CRP) has shown promise as a measure to reduce unnecessary antibiotic prescribing in respiratory tract infections (RTI), but its use in primary ...

In a recent study, immune-inflammatory index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio were associated with infection of respiratory syncytial virus (RSV) in children. High ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global C-reactive protein test market since 2018 and the market is poised to grow by USD 110.41 million during 2019-2023, progressing at a ...

New York, March 05, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type, By Detection ...

DUBLIN--(BUSINESS WIRE)--The "C-reactive Protein Testing Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The major factors propelling ...

DUBLIN, March 11, 2020 /PRNewswire/ -- The "C-Reactive Protein Testing Market Size, Share & Trends Analysis Report by Assay Type, by Detection Range, by Disease Area (Cancer, Endometriosis, ...

English-speaking women age ≥ 60 years, newly diagnosed with primary breast cancer (stage 0-III), and frequency-matched controls were enrolled from September 2010 to March 2020; women with dementia, ...